On Friday, May 16, 2003, at 12:57 Europe/London, Paul Masters wrote:
> http://bmj.com/cgi/content/full/326/7398/0-f
>
> At last some evidence-based clinical biochemistry! Level 1b no less.
> The link is from today's BMJ indicating an evidence-based range of 0.5
> - 0.8
> ng/ml as optimum for men with heart failure. (Only men seem to benefit
> from
> this drug for this indication: most patients on digoxin have it for
> atrial
> fibrillation). We should now be considering how to incorporate this
> information in our reports.
...well, In Liverpool they could print the evidence on the back of the
report forms, but I think we'll hyperlink to the BMJ article...
Jonathan
>
> Paul
>
> Dr Paul Masters
> Consultant Chemical Pathologist
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|